Effect of amlodipine therapy on the monoclonal antibody 3G8-induced calcium signal in polymorphonuclear leukocytes of hemodialysis patients

被引:3
作者
Ahmed, A
Krol, E
Smogorzewski, M
Massry, SG
机构
[1] LAC USC Med Ctr, Div Nephrol, Sch Med, Los Angeles, CA 90033 USA
[2] LAC USC Med Ctr, Dept Med, Sch Med, Los Angeles, CA 90033 USA
关键词
amlodipine; chronic renal failure; calcium channels; cytosolic calcium;
D O I
10.1159/000013507
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic renal failure is associated with impaired phagocytosis, This was attributed to the PTH-induced elevation of basal levels of [Ca2+](i) of polymorphonuclear leukocytes (PMNLs) and to the small calcium transient induced by the ligation of the Fc gamma RIII receptors of these cells with 3G8 monoclonal antibodies, The blocking of the action of PTH on the PMNLs of patients with chronic renal failure by their treatment with a calcium channel blocker normalized the basal levels of [Ca2+](i) of the PMNLs and reversed the defect in their phagocytic property, It is not known whether such therapy would also restore the calcium transient in the PMNLs in response to 3G8 monoclonal antibody to normal. We examined this issue in 12 normal subjects and 18 hemodialysis patients; 9 of them were treated with the calcium channel blocker, amlodipine, and the other 9 did not receive such therapy, The treatment with amlodipine normalized [Ca2+](i) of PMNLs as well as the calcium transient in response to 3G8 monoclonal antibody and reversed the defect in their phagocytosis, It is concluded that chronic renal failure is associated with deranged calcium homeostasis of PMNLs which causes abnormalities in the function of Fc gamma RIII receptors and consequently results in impaired phagocytosis. Therapy with a calcium channel blocker can reverse all these derangements in metabolism and function of PMNLs.
引用
收藏
页码:505 / 508
页数:4
相关论文
共 14 条
[1]   A SELECTIVE DEFECT IN ARACHIDONIC-ACID RELEASE FROM MACROPHAGE MEMBRANES IN HIGH POTASSIUM MEDIA [J].
ADEREM, AA ;
SCOTT, WA ;
COHN, ZA .
JOURNAL OF CELL BIOLOGY, 1984, 99 (04) :1235-1241
[2]   IMPAIRED PHAGOCYTOSIS IN DIALYSIS PATIENTS - STUDIES ON MECHANISMS [J].
ALEXIEWICZ, JM ;
SMOGORZEWSKI, M ;
FADDA, GZ ;
MASSRY, SG .
AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (02) :102-111
[3]   Time course of the effect of nifedipine therapy and its discontinuation on [Ca2+](i) and phagocytosis of polymorphonuclear leukocytes from hemodialysis patients [J].
Alexiewicz, JM ;
Smogorzewski, M ;
Gill, SK ;
Akmal, M ;
Massry, SG .
AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (01) :12-16
[4]   EFFECT OF TREATMENT OF HEMODIALYSIS-PATIENTS WITH NIFEDIPINE ON METABOLISM AND FUNCTION OF POLYMORPHONUCLEAR [J].
ALEXIEWICZ, JM ;
SMOGORZEWSKI, M ;
KLIN, M ;
AKMAL, M ;
MASSRY, SG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) :440-444
[5]   IMPAIRED PHAGOCYTOSIS IN CHRONIC-RENAL-FAILURE IS MEDIATED BY SECONDARY HYPERPARATHYROIDISM [J].
CHERVU, I ;
KIERSZTEJN, M ;
ALEXIEWICZ, JM ;
FADDA, GZ ;
SMOGORZEWSKI, M ;
MASSRY, SG .
KIDNEY INTERNATIONAL, 1992, 41 (06) :1501-1505
[6]  
FABER DL, 1993, J IMMUNOL, V150, P4364
[7]   OPTIMAL CONDITIONS FOR SIMULTANEOUS PURIFICATION OF MONONUCLEAR AND POLYMORPHONUCLEAR LEUKOCYTES FROM HUMAN-BLOOD BY THE HYPAQUE-FICOLL METHOD [J].
FERRANTE, A ;
THONG, YH .
JOURNAL OF IMMUNOLOGICAL METHODS, 1980, 36 (02) :109-117
[8]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[9]  
KOKOT K, 1987, MINER ELECTROL METAB, V13, P133
[10]   RECEPTORS FOR COMPLEMENT ON LEUKOCYTES [J].
LAY, WH ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1968, 128 (05) :991-+